Rogers S, Lew V
PLoS Comput Biol. 2021; 17(3):e1008496.
PMID: 33690597
PMC: 7946313.
DOI: 10.1371/journal.pcbi.1008496.
Larkin M, Nathan D, Bebu I, Krause-Steinrauf H, Herman W, Higgins J
Diabetes Technol Ther. 2019; 21(12):682-690.
PMID: 31393176
PMC: 7207016.
DOI: 10.1089/dia.2019.0202.
Fitzhugh C, Cordes S, Taylor T, Coles W, Roskom K, Link M
Blood. 2017; 130(17):1946-1948.
PMID: 28887325
PMC: 5659067.
DOI: 10.1182/blood-2017-03-772392.
Suthammarak W, Numpraphrut P, Charoensakdi R, Neungton N, Tunrungruangtavee V, Jaisupa N
Oxid Med Cell Longev. 2016; 2016:1293036.
PMID: 27703599
PMC: 5040814.
DOI: 10.1155/2016/1293036.
Quinn C, Smith E, Arbabi S, Khera P, Lindsell C, Niss O
Am J Hematol. 2016; 91(12):1195-1201.
PMID: 27648808
PMC: 5118160.
DOI: 10.1002/ajh.24562.
Mathematical modeling of erythrocyte chimerism informs genetic intervention strategies for sickle cell disease.
Altrock P, Brendel C, Renella R, Orkin S, Williams D, Michor F
Am J Hematol. 2016; 91(9):931-7.
PMID: 27299299
PMC: 5093908.
DOI: 10.1002/ajh.24449.
Models for the red blood cell lifespan.
Shrestha R, Horowitz J, Hollot C, Germain M, Widness J, Mock D
J Pharmacokinet Pharmacodyn. 2016; 43(3):259-74.
PMID: 27039311
PMC: 4887310.
DOI: 10.1007/s10928-016-9470-4.
Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.
Smith E, Cohen R
J Diabetes Sci Technol. 2015; 9(3):696-700.
PMID: 25691656
PMC: 4604523.
DOI: 10.1177/1932296815572255.
Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation.
Khera P, Smith E, Lindsell C, Rogge M, Haggerty S, Wagner D
Am J Hematol. 2014; 90(1):50-55.
PMID: 25293624
PMC: 4276493.
DOI: 10.1002/ajh.23866.
Measurement of posttransfusion red cell survival with the biotin label.
Mock D, Widness J, Veng-Pedersen P, Strauss R, Cancelas J, Cohen R
Transfus Med Rev. 2014; 28(3):114-25.
PMID: 24969019
PMC: 4122272.
DOI: 10.1016/j.tmrv.2014.03.003.
Mean remaining life span: a new clinically relevant parameter to assess the quality of transfused red blood cells.
Kuruvilla D, Nalbant D, Widness J, Veng-Pedersen P
Transfusion. 2014; 54(10 Pt 2):2724-9.
PMID: 24611672
PMC: 4404519.
DOI: 10.1111/trf.12562.
Measurement of red cell lifespan and aging.
Franco R
Transfus Med Hemother. 2013; 39(5):302-7.
PMID: 23801920
PMC: 3678251.
DOI: 10.1159/000342232.
When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity.
Cohen R, Lindsell C
Diabetes Care. 2012; 35(12):2421-3.
PMID: 23173128
PMC: 3507598.
DOI: 10.2337/dc12-1479.
Changes in the properties of normal human red blood cells during in vivo aging.
Franco R, Puchulu-Campanella M, Barber L, Palascak M, Joiner C, Low P
Am J Hematol. 2012; 88(1):44-51.
PMID: 23115087
PMC: 4067949.
DOI: 10.1002/ajh.23344.
Comparison of red blood cell survival in sheep determined using red blood cells labeled with either biotin at multiple densities or [14C]cyanate: validation of a model to study human physiology and disease.
Mock D, Matthews N, Zhu S, Strauss R, Schmidt R, Zimmerman M
Transfusion. 2012; 52(5):963-73.
PMID: 22229348
PMC: 3564637.
DOI: 10.1111/j.1537-2995.2011.03512.x.
Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.
Leslie R, Cohen R
J Diabetes Sci Technol. 2010; 3(4):635-43.
PMID: 20144305
PMC: 2769979.
DOI: 10.1177/193229680900300403.
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.
Cohen R, Franco R, Khera P, Smith E, Lindsell C, Ciraolo P
Blood. 2008; 112(10):4284-91.
PMID: 18694998
PMC: 2581997.
DOI: 10.1182/blood-2008-04-154112.